Previous 10 | Next 10 |
2024-03-28 10:47:02 ET Microsoft Corporation (MSFT) MSFT is trading DOWN for the last 4 days, and it at trading at $421.22 with volume of 3,479,535 and a one day change of $-0.21 (-0.05%). Microsoft Corporation has a 52-week low of 272.05 and a 52-week high of $430.82. The business'...
2024-03-26 11:43:00 ET More on CRISPR Technology Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript) Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript) Editas Medicine, Inc. (EDIT...
2024-03-26 02:33:22 ET Summary Regulatory approvals for Crispr Therapeutics' CASGEVY program are increasing, expanding the potential market for the treatment. Government support, including public funds, is likely to be available for CASGEVY in approved countries. Private insur...
2024-03-23 06:45:00 ET Price matters. That's true whether we're talking about cars, houses, laptops, or anything else -- including stocks. Three Motley Fool contributors had price in mind when choosing Axsome Therapeutics (NASDAQ: AXSM) , CRISPR Therapeutics (NASDAQ: CRSP)...
2024-03-18 11:02:46 ET More on bluebird bio Bluebird Bio: Innovative Therapies, Monetary Setbacks Biotech And Pharma Diversification Pays Off bluebird bio's Lyfgenia: Navigating Commercialization Challenges In SCD Biggest stock movers today: EQT, MESO, Crypto...
2024-03-16 08:45:00 ET CRISPR Therapeutics (NASDAQ: CRSP) is gaining in prominence. The gene-editing specialist has made tremendous clinical and regulatory progress since its 2016 initial public offering, leading to market-beating returns even if it hasn't always been smooth sailing...
2024-03-13 14:25:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table biotech stocks . T...
2024-03-08 13:47:20 ET More on CRISPR Therapeutics Crispr Therapeutics: I'm Not Betting Against Gene Editing This Time (Upgrade) Crispr Therapeutics: Cautiously Optimistic CRISPR Therapeutics AG (CRSP) Presents at Citi 2024 Virtual Oncology Leadership Summit Conferen...
2024-03-05 18:53:38 ET CRISPR Therapeutics (NASDAQ: CRSP) was a standout in the market last month as its shares charged 34% higher, according to data provided by S&P Global Market Intelligence . The biotech stock sustained its momentum from prior months with a strong qua...
2024-03-01 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
2024-05-15 11:11:00 ET CRISPR Therapeutics (NASDAQ: CRSP) closed last week down 8.5% after reporting first-quarter "earnings" results that looked a lot more like losses. Lacking a big milestone payment like the one in Q1 2023, CRISPR's revenue plummeted 99.5% year over year, and the...
ZUG, Switzerland and BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating...